Fundraise

Byzfunder backs $165M ABS deal

What's the deal? ByzfunderDealroom has a profile for this one. Try Dealroom →, a business capital finance company, is backing a $165 million asset-backed securities (ABS) transaction. The deal is secured by a revolving pool of business loans and merchant cash advances.

The revolving period runs until May 31, 2029 — roughly 36 months after the initial closing date. Letters of credit sized to cover six months of interest payments, plus a cushion, provide additional credit support to the notes.

The transaction follows a sequential repayment structure, requiring each note class to hit a required overcollateralisation percentage before the next subordinate class starts receiving principal.

Why now? The deal arrives during an active stretch for the ABS market. Recent weeks have seen sizeable transactions from Avis Budget ($568.2 million), Banker's Healthcare ($396 million), HyundaiDealroom has a profile for this one. Try Dealroom → ($1.2 billion), and Westlake Automobile ($1.4 billion), signalling strong investor appetite for structured products backed by diverse asset types.

What could go wrong? Business loans and merchant cash advances carry inherent credit risk, particularly if economic conditions deteriorate. Small-business borrowers tend to be more vulnerable to downturns than consumers or large corporates. The 36-month revolving period also introduces uncertainty about the quality of assets added to the pool over time.

The signal: Byzfunder, an early-growth alternative finance provider focused on small and medium-sized businesses, is using the securitisation market to scale its lending capacity — a playbook increasingly favoured by non-bank lenders seeking cheaper funding. The $165 million deal lands in a period of robust ABS issuance across asset classes, suggesting investor confidence in structured products remains firm even as scrutiny of less traditional collateral, such as merchant cash advances, intensifies.

Read more: asreport.americanbanker.com

More top stories